FRONTIER CAPITAL MANAGEMENT CO LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$2,780,000
+45.9%
178,136
-11.7%
0.02%
+23.5%
Q3 2020$1,906,000
-2.8%
201,722
-7.8%
0.02%0.0%
Q2 2020$1,961,000
+26.4%
218,874
-10.2%
0.02%0.0%
Q1 2020$1,552,000
-25.5%
243,672
-2.1%
0.02%
+13.3%
Q4 2019$2,084,000
-16.2%
248,959
-9.4%
0.02%
-21.1%
Q3 2019$2,488,000
-21.5%
274,908
-6.6%
0.02%
-20.8%
Q2 2019$3,171,000
-20.0%
294,448
-29.1%
0.02%
-14.3%
Q1 2019$3,962,000
-22.2%
415,256
-6.3%
0.03%
-31.7%
Q4 2018$5,090,000
-33.4%
443,386
-1.7%
0.04%
-16.3%
Q3 2018$7,647,000
+15.2%
451,156
-3.5%
0.05%
+4.3%
Q2 2018$6,637,000
-26.5%
467,381
-1.7%
0.05%
-28.8%
Q1 2018$9,032,000
+15.3%
475,388
-0.5%
0.07%
+15.8%
Q4 2017$7,835,000
+7.1%
477,726
-2.1%
0.06%
+7.5%
Q3 2017$7,317,000
+68.0%
487,788
-1.5%
0.05%
+65.6%
Q2 2017$4,356,000
+67.6%
495,028
-1.0%
0.03%
+68.4%
Q1 2017$2,599,000
+67.4%
499,803
-1.8%
0.02%
+58.3%
Q4 2016$1,553,000
-34.7%
509,132
-1.0%
0.01%
-36.8%
Q3 2016$2,380,000
-20.0%
514,076
+0.0%
0.02%
-20.8%
Q2 2016$2,976,000
-40.6%
513,930
-37.9%
0.02%
-40.0%
Q1 2016$5,007,000
-33.9%
827,567
-0.3%
0.04%
-36.5%
Q4 2015$7,575,000
+24.0%
829,651
-23.4%
0.06%
+23.5%
Q3 2015$6,107,000
-71.0%
1,082,787
-43.1%
0.05%
-66.2%
Q2 2015$21,089,000
-37.9%
1,901,604
-12.2%
0.15%
-38.4%
Q1 2015$33,978,000
+20.0%
2,166,975
+16.4%
0.24%
+17.8%
Q4 2014$28,314,000
+22.0%
1,861,558
-13.5%
0.21%
+11.2%
Q3 2014$23,211,000
-31.6%
2,152,179
-3.2%
0.19%
-25.2%
Q2 2014$33,936,000
+42.5%
2,222,395
+68.7%
0.25%
+45.3%
Q1 2014$23,815,0001,317,1900.17%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders